Use of magnesium sulfate before 32 weeks of gestation: a European population-based cohort study

about

MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)-implementation of a national guideline in Canada.Fetal Neuroprotection by Magnesium Sulfate: From Translational Research to Clinical Application.

P2860

Q47564938-CBCD34B2-C821-4315-A6AE-5604D10B3E3B Q55264774-630E7FF8-7917-4782-B634-00C516AD390F

P2860

Use of magnesium sulfate before 32 weeks of gestation: a European population-based cohort study

Item

http://www.wikidata.org/entity/Q37612215

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Use of magnesium sulfate befor ...... population-based cohort study

@en

Use of magnesium sulfate befor ...... population-based cohort study.

@nl

type

Item

label

Use of magnesium sulfate befor ...... population-based cohort study

@en

Use of magnesium sulfate befor ...... population-based cohort study.

@nl

prefLabel

Use of magnesium sulfate befor ...... population-based cohort study

@en

Use of magnesium sulfate befor ...... population-based cohort study.

@nl

P1476

Use of magnesium sulfate befor ...... population-based cohort study

@en

P2093

A Piedvache

http://www.w3.org/2001/XMLSchema#string

H T Wolf

http://www.w3.org/2001/XMLSchema#string

L Huusom

http://www.w3.org/2001/XMLSchema#string

S Schmidt

http://www.w3.org/2001/XMLSchema#string

T Weber

http://www.w3.org/2001/XMLSchema#string

and the EPICE Research Group

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment with magnesium sulphate in pre-term birth: A systematic review and meta-analysis of observational studies

Magnesium sulphate for preventing preterm birth in threatened preterm labour

Magnesium sulphate and other anticonvulsants for women with pre-eclampsia

Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus

System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe.

Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis.

Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: a case study in Zambia.

Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines.

Health system barriers to access and use of magnesium sulfate for women with severe pre-eclampsia and eclampsia in Pakistan: evidence for policy and practice

Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infants

P304

e013952

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJOPEN-2016-013952

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer Zeitlin

Mikael Norman

P577

2017-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28132012

http://www.w3.org/2001/XMLSchema#string

P921

magnesium sulfate

Béésh Łikoní

P932

5278293

http://www.w3.org/2001/XMLSchema#string

Use of magnesium sulfate before 32 weeks of gestation: a European population-based cohort study

about

P2860

P2860

Use of magnesium sulfate before 32 weeks of gestation: a European population-based cohort study

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932